|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.90 CNY | -1.36% |
|
-0.13% | +5.51% |
| 07-20 | Tasly Pharmaceutical Gets China Greenlight for Stroke Drug Trial | MT |
| 07-14 | Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 23.75B 3.52B 3.06B 2.85B 2.62B 4.94B 335B 5.02B 33.64B 13.17B 167B 13.21B 12.91B 551B | P/E 2026 * |
17.7x | P/E 2027 * | 14.8x |
|---|---|---|---|---|---|
| Enterprise Value | 22.49B 3.33B 2.89B 2.7B 2.48B 4.68B 317B 4.76B 31.86B 12.48B 158B 12.51B 12.23B 522B | EV / Sales 2026 * |
2.5x | EV / Sales 2027 * | 1.84x |
| Free-Float |
47.15% | Yield 2026 * |
2.83% | Yield 2027 * | 3.23% |
| 1 day | -1.36% | ||
| 1 week | -0.13% | ||
| Current month | -1.36% | ||
| 1 month | +13.57% | ||
| 3 months | +5.09% | ||
| 6 months | +7.14% | ||
| Current year | +5.51% |
| 1 week | 15.68 |  | 16.22 |
| 1 month | 13.78 | | 16.24 |
| Current year | 12.9 | | 16.24 |
| 1 year | 12.9 | | 17.69 |
| 3 years | 12.24 | | 18 |
| 5 years | 9.2 | | 18 |
| 10 years | 9.2 | | 34.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Yong Cai
CEO | Chief Executive Officer | 54 | 2024-05-07 |
Jie Wei
DFI | Director of Finance/CFO | 49 | 2018-07-08 |
Xin Yang
CIO | Chief Investment Officer | 45 | 2025-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ai Jian Wang
BRD | Director/Board Member | 72 | 2021-06-01 |
Jin Yong Cai
BRD | Director/Board Member | 54 | 2006-03-24 |
Ke Xin Li
BRD | Director/Board Member | 58 | 2024-05-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.36% | -0.13% | -4.56% | +15.64% | 3.57B | |
| -1.08% | +2.29% | -7.11% | -2.86% | 13.96B | |
| -0.80% | +2.67% | -29.01% | -49.86% | 5.34B | |
| +1.43% | +6.95% | +7.16% | +11.02% | 5.16B | |
| -1.01% | -0.12% | +2.26% | -32.06% | 4.18B | |
| -1.15% | +2.35% | -2.35% | -2.70% | 3.79B | |
| +0.04% | -0.37% | -0.81% | +7.01% | 3.66B | |
| +1.27% | +0.31% | -13.17% | -21.65% | 2.46B | |
| +0.39% | +3.40% | -1.58% | +53.42% | 1.92B | |
| +0.48% | +3.38% | -39.23% | -11.73% | 1.76B | |
| Average | -0.18% | +2.68% | -8.84% | -3.38% | 4.58B | |
| Weighted average by Cap. | -0.45% | +2.51% | -7.43% | -6.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9B 1.33B 1.16B 1.08B 992M 1.87B 127B 1.9B 12.74B 4.99B 63.3B 5B 4.89B 209B | 9.78B 1.45B 1.26B 1.18B 1.08B 2.03B 138B 2.07B 13.86B 5.43B 68.84B 5.44B 5.32B 227B |
| Net income | 1.36B 202M 175M 164M 150M 283M 19.21B 288M 1.93B 755M 9.58B 757M 740M 31.59B | 1.61B 238M 207M 193M 177M 334M 22.69B 340M 2.28B 892M 11.31B 894M 874M 37.32B |
| Net Debt | -1.26B -186M -162M -151M -139M -262M -17.76B -266M -1.78B -698M -8.86B -700M -684M -29.21B | -5.78B -855M -743M -694M -637M -1.2B -81.5B -1.22B -8.18B -3.2B -40.64B -3.21B -3.14B -134B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-03 | CN¥15.90 | -1.36% | 16,376,039 |
| 26-07-31 | CN¥16.12 | +1.51% | 21,670,879 |
| 26-07-30 | CN¥15.88 | -0.44% | 17,778,996 |
| 26-07-29 | CN¥15.95 | +1.40% | 22,063,789 |
| 26-07-28 | CN¥15.73 | -1.19% | 15,595,796 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600535 Stock
Select your edition
All financial news and data tailored to specific country editions
